With little fanfare, the Biden administration stacked a critical committee that helps set U.S. vaccination policy with new ...

( MENAFN - GlobeNewsWire - Nasdaq) Dublin, Jan. 30, 2025 (GLOBE NEWSWIRE) -- The "Pharmaceutical Regulatory Affairs in Asia Training Course" has been added to ResearchAndMarkets.com's offering.

With an estimated 2.1 million children in Nigeria and almost one million in Ethiopia1 classed as 'zero dose', having never ...

Ahead of his confirmation hearing this week, Robert F. Kennedy Jr., President Donald Trump’s nominee for HHS Secretary, has ...

This Fool considers how two low-risk and well-established FTSE shares could offer stability and growth during a period of market volatility.

The stock market can be a scary place for those who aren’t prepared. Our writer outlines three ways we might avoid getting caught out.

AutoGen represents Microsoft’s latest attempt to address the challenges of building multi-agent systems for enterprise applications. This article explores what this means for the state of agentic AI ...

Credit: R Photography Background via Shutterstock. The first day of the JP Morgan Healthcare Conference held in San Francisco, California from 13 January to 15 January 2025 began with Johnson & ...

Both assets are poised to enter registrational studies under accelerated approval pathways, according to Jefferies. GSK to Stay Out of Obesity—but not GLP-1s At JPM25 on Monday, GSK Chief Scientific ...

GSK plc GSK expects strong momentum in the specialty business segment to continue with growth from existing assets. At the JPMorgan Healthcare Conference, the European healthcare giant noted there ...

Following GSK’s deal-heavy end to 2024, Chief Scientific Officer Tony Wood, Ph.D., doesn’t expect the trend to let up in the new year, zeroing in on partnerships that can expand knowledge ...

© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...